Woodstock Corp’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.8M | Sell |
18,345
-775
| -4% | -$183K | 0.48% | 58 |
|
|
2026
Q1 | $3.82M | Sell |
19,120
-885
| -4% | -$175K | 0.34% | 68 |
|
|
2025
Q4 | $3.78M | Sell |
20,005
-20
| -0.1% | -$3.84K | 0.32% | 67 |
|
|
2025
Q3 | $3.55M | Sell |
20,025
-9,472
| -32% | -$1.41M | 0.31% | 71 |
|
|
2025
Q2 | $3.35M | Buy |
29,497
+100
| +0.3% | +$10.7K | 0.31% | 72 |
|
|
2025
Q1 | $3.09M | Sell |
29,397
-14
| -0% | -$1.58K | 0.31% | 73 |
|
|
2024
Q4 | $3.15M | Buy |
29,411
+200
| +0.7% | +$22.6K | 0.3% | 71 |
|
|
2024
Q3 | $2.92M | Buy |
29,211
+100
| +0.3% | +$10.1K | 0.28% | 77 |
|
|
2024
Q2 | $2.45M | Sell |
29,111
-1,000
| -3% | -$79.6K | 0.25% | 78 |
|
|
2024
Q1 | $2.2M | Hold |
30,111
| – | – | 0.23% | 82 |
|
|
2023
Q4 | $2.15M | Sell |
30,111
-4,049
| -12% | -$239K | 0.25% | 79 |
|
|
2023
Q3 | $2.05M | Sell |
34,160
-12,635
| -27% | -$832K | 0.26% | 76 |
|
|
2023
Q2 | $3.37M | Sell |
46,795
-5,809
| -11% | -$436K | 0.4% | 65 |
|
|
2023
Q1 | $3.87M | Sell |
52,604
-2,410
| -4% | -$171K | 0.49% | 59 |
|
|
2022
Q4 | $3.67M | Sell |
55,014
-43,881
| -44% | -$2.85M | 0.49% | 61 |
|
|
2022
Q3 | $5.31M | Sell |
98,895
-3,537
| -3% | -$208K | 0.79% | 47 |
|
|
2022
Q2 | $5.7M | Sell |
102,432
-240
| -0.2% | -$13.6K | 0.79% | 48 |
|
|
2022
Q1 | $7.21M | Sell |
102,672
-7,400
| -7% | -$537K | 0.84% | 40 |
|
|
2021
Q4 | $10.6M | Hold |
110,072
| – | – | 1.11% | 30 |
|
|
2021
Q3 | $9.57M | Sell |
110,072
-176
| -0.2% | -$13.6K | 1.12% | 32 |
|
|
2021
Q2 | $9.02M | Hold |
110,248
| – | – | 1.06% | 35 |
|
|
2021
Q1 | $10.5M | Sell |
110,248
-1,133
| -1% | -$107K | 1.33% | 27 |
|
|
2020
Q4 | $6.91M | Buy |
111,381
+32
| +0% | +$1.82K | 0.92% | 38 |
|
|
2020
Q3 | $6.62M | Sell |
111,349
-2,341
| -2% | -$160K | 1.07% | 34 |
|
|
2020
Q2 | $7.93M | Buy |
113,690
+170
| +0.1% | +$10.8K | 1.35% | 29 |
|
|
2020
Q1 | $5.15M | Sell |
113,520
-1,077
| -0.9% | -$61K | 1.05% | 36 |
|
|
2019
Q4 | $7.46M | Buy |
114,597
+386
| +0.3% | +$25.8K | 1.21% | 36 |
|
|
2019
Q3 | $7.09M | Buy |
114,211
+105
| +0.1% | +$6.59K | 1.24% | 31 |
|
|
2019
Q2 | $8.13M | Buy |
114,106
+689
| +0.6% | +$50.7K | 1.42% | 24 |
|
|
2019
Q1 | $8.89M | Buy |
113,417
+1,593
| +1% | +$121K | 1.59% | 22 |
|
|
2018
Q4 | $9.47M | Buy |
111,824
+4,891
| +5% | +$521K | 1.9% | 13 |
|
|
2018
Q3 | $18.3M | Sell |
106,933
-1,904
| -2% | -$287K | 3.09% | 4 |
|
|
2018
Q2 | $14.1M | Sell |
108,837
-1,724
| -2% | -$192K | 2.59% | 4 |
|
|
2018
Q1 | $11.4M | Sell |
110,561
-283
| -0.3% | -$28K | 2.15% | 7 |
|
|
2017
Q4 | $9.47M | Buy |
110,844
+341
| +0.3% | +$29.6K | 1.75% | 18 |
|
|
2017
Q3 | $9.39M | Buy |
110,503
+1,170
| +1% | +$92.6K | 1.79% | 16 |
|
|
2017
Q2 | $8.28M | Buy |
109,333
+2,068
| +2% | +$145K | 1.62% | 23 |
|
|
2017
Q1 | $7.08M | Buy |
107,265
+1,004
| +0.9% | +$66K | 1.43% | 29 |
|
|
2016
Q4 | $6.74M | Sell |
106,261
-1,372
| -1% | -$86.6K | 1.37% | 30 |
|
|
2016
Q3 | $6.85M | Sell |
107,633
-3,035
| -3% | -$223K | 1.4% | 30 |
|
|
2016
Q2 | $8.23M | Sell |
110,668
-577
| -0.5% | -$42.8K | 1.7% | 17 |
|
|
2016
Q1 | $7.43M | Hold |
111,245
| – | – | 1.56% | 21 |
|
|
2015
Q4 | $7.52M | Sell |
111,245
-1,194
| -1% | -$73.7K | 1.65% | 17 |
|
|
2015
Q3 | $6.01M | Sell |
112,439
-2,084
| -2% | -$126K | 1.37% | 27 |
|
|
2015
Q2 | $7.21M | Buy |
114,523
+449
| +0.4% | +$24.5K | 1.36% | 29 |
|
|
2015
Q1 | $5.49M | Buy |
114,074
+19,685
| +21% | +$754K | 1.02% | 41 |
|
|
2014
Q4 | $3.13M | Buy |
94,389
+10,668
| +13% | +$347K | 0.58% | 59 |
|
|
2014
Q3 | $2.45M | Buy |
83,721
+23,764
| +40% | +$789K | 0.47% | 65 |
|
|
2014
Q2 | $2.33M | Buy |
59,957
+18,050
| +43% | +$732K | 0.41% | 73 |
|
|
2014
Q1 | $1.76M | Buy |
41,907
+27,754
| +196% | +$1.16M | 0.33% | 83 |
|
|
2013
Q4 | $464K | Buy |
+14,153
| New | +$461K | 0.08% | 123 |
|
Other funds holding LGND
JT
CAM
Woodstock Corp's LGND Position: Q2 2026 in Review
Woodstock Corp reduced its Ligand Pharmaceuticals (LGND) stake by 4.1% in Q2 2026, selling an estimated $183K and leaving 18,345 shares worth $5.8M. The position accounts for 0.48% of the portfolio, ranked #58.
Woodstock Corp first reported a position in LGND in Q4 2013 and has held it in 51 quarters since. The position peaked at $18.3M in Q3 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Woodstock Corp held 18,345 shares of Ligand Pharmaceuticals worth $5.8M as of Q2 2026.
- Woodstock Corp sold 775 Ligand Pharmaceuticals shares in Q2 2026, an estimated $183K.
- Ligand Pharmaceuticals made up 0.48% of Woodstock Corp's portfolio in Q2 2026, its #58 holding.
- Woodstock Corp first reported a position in Ligand Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
- Woodstock Corp's Ligand Pharmaceuticals position peaked at $18.3M in Q3 2018.
- 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Woodstock Corp's 13F filing for Q2 2026, filed 13 Jul 2026.